Ys Life Science Co Ltd, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRAVOPROST, with a corresponding US DMF Number 24907.
Remarkably, this DMF maintains an Active status since its submission on April 18, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 30, 2024, and payment made on July 26, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II